Ubiquitin C-terminal hydrolase-L1 has prognostic relevance and is a therapeutic target for high-grade neuroendocrine lung cancers.
Cancer Sci. 2020 Feb;111(2):610-620. doi: 10.1111/cas.14284. Epub 2020 Jan 19.
Cancer Sci. 2020.
PMID: 31845438
Free PMC article.